what are the risks of glp-1 for weight loss GLP-1: Diabetes Drug Changing How We Think About Glucagon-like Receptor-1 agonists for obesity:

Most people tolerate both medication types well after initial adjustment

The described patient likely experienced adverse effects- specifically nausea and persistent vomiting-following administration of a GLP-1RA (two days after the injection) ( We present a case of a patient with newly diagnosed type 2 diabetes who developed severe euDKA, triggered by the combination of an SGLT2i (dapagliflozin) and GLP1 RA (semaglutide)

A study found in BMJ Open Diabetes Research & Care confirms that even when consumed in reasonable amounts, it has minimal impact on blood sugar

They are compounded by licensed pharmacies under provider supervision

The discomfort is usually minimal and temporary, with most people experiencing only slight soreness or tenderness at the injection site

I have a lot of resources below to help you reach a higher protein and fiber intake